Academic article

• Cornelia Schuster; Lars A. Akslen; Tomasz Stokowy et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (external link)
• Cornelia Schuster; Hans Petter Eikesdal; Hanne Eknes Puntervoll et al. (2012). Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. (external link)
• Cornelia Schuster; Lars A. Akslen; Oddbjørn Straume (2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (external link)
• Cornelia Schuster; Lars Andreas Akslen; Oddbjørn Straume (2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (external link)
• Elin Aamdal; Kari Dolven Jacobsen; Oddbjørn Straume et al. (2021). Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up. (external link)
• Emilia Signe Hugdahl; Ingeborg M. Bachmann; Cornelia Schuster et al. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. (external link)
• Rakel Brendsdal Forthun; Randi Hovland; Cornelia Schuster et al. (2019). ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab. (external link)

Conference abstract

• Cornelia Schuster; Gro Gausdal; Bjørn Tore Gjertsen et al. (2018). Update on the randomised phase Ib/II study of the selective small molecule AXL inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib or pembrolizumab in patients with metastatic melanoma. (external link)

Doctoral thesis (PhD)

• Cornelia Schuster; Oddbjørn Straume (2016). Investigation of predictive markers in patients with metastatic melanoma treated with bevacizumab. (external link)

Academic book chapter

• Hanna Dillekås; Cornelia Schuster; Kjersti Davidsen et al. (2022). The Role of the Microenvironment in Tumor Promoting Stress Responses. (external link)
• Oddbjørn Straume; Cornelia Schuster (2017). The Tumor Microenvironment in Cutaneous Melanoma: Friend or Foe. (external link)

Academic literature review

• Kremena Petrova Trichkova; Franziska Stilla Maria Görtler; Line Bjørge et al. (2024). Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors. (external link)

See a complete overview of publications in Cristin.